Scopus BioPharma, a preclinical biotech developing immuno-oncology gene therapies for cancer, lowered the proposed deal size for its upcoming IPO on Tuesday. The New York, NY-based company now plans ...
Scopus is an interdisciplinary database of peer-reviewed literature, with strong coverage in sciences, engineering and social sciences. This workshop will focus on how to conduct and expand searches ...
Scopus, an internationally recognized database for evaluating the quality and impact of scientific research, has announced ...
If you want to know who really controls Scopus BioPharma Inc. (NASDAQ:SCPS), then you'll have to look at the makeup of its share registry. Large companies usually have institutions as shareholders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results